[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353867-105":59,"doc-detail-353867-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","integrating-single-cell-and-spatial-transcriptomics-with-pan-cancer-bulk-sequencing-identifies-osr2-as-a-multifaceted-biomarker-for-prognosis-and-tumor-immunity","Integrating single-cell and spatial transcriptomics with pan-cancer bulk sequencing identifies OSR2 as a multifaceted biomarker for prognosis and tumor immunity","","OSR2 is implicated in diverse physiological functions and cancer development, yet its mechanisms and clinical relevance remain incompletely defined. This study integrates single-cell RNA sequencing, spatial transcriptomics, and pan-cancer RNA sequencing to characterize OSR2 expression across immune cells, renal carcinoma tissue localization, and 38 cancer types. OSR2 is evaluated for prognostic value, links to patient survival, and associations with immunomodulatory factors, immune checkpoints, and immune-cell infiltration patterns.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/integrating-single-cell-and-spatial-transcriptomics-with-pan-cancer-bulk-sequencing-identifies-osr2-as-a-multifaceted-biomarker-for-prognosis-and-tumor-immunity/353867/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/integrating-single-cell-and-spatial-transcriptomics-with-pan-cancer-bulk-sequencing-identifies-osr2-as-a-multifaceted-biomarker-for-prognosis-and-tumor-immunity/353867.png","ImageObject",300,407,{"name":92,"@type":93},"Mia  ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What was the main aim of the study on OSR2?","Question",{"text":113,"@type":114},"To examine OSR2 gene expression across cancers and assess whether it can serve as a prognostic biomarker and therapeutic target, including links to tumor immunity.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How did the study evaluate OSR2 expression across different data types?",{"text":118,"@type":114},"It used single-cell RNA sequencing to assess OSR2 in immune cells, spatial transcriptomics to study OSR2 spatial expression in renal carcinoma tissues, and RNA sequencing from TCGA to test differential expression across 38 cancer types.",{"name":120,"@type":111,"acceptedAnswer":121},"What did the study find regarding OSR2 and patient prognosis?",{"text":122,"@type":114},"Higher OSR2 levels were associated with poorer prognosis in multiple cancers, and OSR2 correlated with clinical factors such as age, gender, and tumor stage.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},353867,1790141608,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},687207024478,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Huang et al. Discover Oncology (2026) 17:416 [https://doi.org/10.1007/s12672-026-04595-z](https://doi.org/10.1007/s12672-026-04595-z)  \nDiscover Oncology  \nANALYSIS Open Access  \nIntegrating single-cell and spatial   \ntranscriptomics with pan-cancer bulk sequencing identifies OSR2 as a multifaceted biomarker for prognosis and tumor immunity  \nZhihui Huang1,2,3, Haohao Yao4, Fanglin Shao4*, Dechao Feng4,5* and Wuran Wei6*  \n*Correspondence:  \nFanglin Shao [fanglinshao.ymedx@gmail.com](fanglinshao.ymedx@gmail.com)[ ](fanglinshao.ymedx@gmail.com)Dechao Feng [dechao.feng@ucl.ac.uk](dechao.feng@ucl.ac.uk)[ ](dechao.feng@ucl.ac.uk)Wuran Wei [weiwuran@scu.edu.cn](weiwuran@scu.edu.cn)[ ](weiwuran@scu.edu.cn)1Operating Room, West China Hospital, Sichuan University, Chengdu, China  \n2West China School of Nursing, Sichuan University, Chengdu, China 3West China Tianfu Hospital, Sichuan University, Chengdu, China 4Urology & Nephrology Center, Department of Urology, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital), Hangzhou Medical College,  \nHangzhou 310014, Zhejiang, China 5Division of Surgery & Interventional Science, University College London,  \nLondon W1W 7TS, UK 6Department of Urology, Institute of Urology, West China Hospital, Sichuan University,  \nChengdu 610041, China  \nAbstract  \nBackground OSR2 plays a key role in various physiological processes and cancer development. Although interest in OSR2’s role in cancer is increasing, its mechanismsand clinical importance are not fully understood. This study thoroughly examines OSR2 gene expression in different cancers and evaluates its potential as a prognostic marker and therapeutic target.  \nMethods A comprehensive pan-cancer analysis utilized single-cell RNA sequencing data from the CIDE database to examine OSR2 expression in various immune cells. Spatial transcriptomics from the CROST database explored OSR2’s spatial expression in renal carcinoma tissues. RNA sequencing data from theTCGA database assessed OSR2’s differential expression in 38 cancer types. The clinical significance of OSR2 was evaluated through its correlation with patient survival outcomes. Additionally, its impact on the tumor immune microenvironment was studied by analyzing associations with immunomodulatory factors, immune checkpoint molecules, and immune cell abundance.  \nResults The pan-cancer analysis revealed that OSR2 expression is often altered in various cancers. It is upregulated in 13 types, notably in gliomas like glioblastoma multiforme and low-grade glioma, and downregulated in 19 types, including kidney and bladder cancers. High OSR2 levels are linked to poor prognosis in several cancers and correlate with clinical factors such as age, gender, and tumor stage. Immunologically, OSR2 expression is positively associated with immunomodulatory and checkpoint genes in cancers like gliomas and colon cancer, but shows an antagonistic relationship with immune cell infiltration in prostate and pancreatic cancers.  \nConclusion The findings suggest that OSR2 expression varies across cancer types and is linked to patient prognosis and changes in the tumor immune environment, making it a promising therapeutic target. Its role in tumor progression and immune interactions indicates its potential as a biomarker for cancer immunotherapy. Further  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unl","cbCaiqV5L5nEDUi0","https://ap.wps.com/l/cbCaiqV5L5nEDUi0","pdf",8727120,18,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Cancer pathogenesis and multiomics approaches\n## OSR2 function and regulation","[{\"question\":\"What was the main aim of the study on OSR2?\",\"answer\":\"To examine OSR2 gene expression across cancers and assess whether it can serve as a prognostic biomarker and therapeutic target, including links to tumor immunity.\"},{\"question\":\"How did the study evaluate OSR2 expression across different data types?\",\"answer\":\"It used single-cell RNA sequencing to assess OSR2 in immune cells, spatial transcriptomics to study OSR2 spatial expression in renal carcinoma tissues, and RNA sequencing from TCGA to test differential expression across 38 cancer types.\"},{\"question\":\"What did the study find regarding OSR2 and patient prognosis?\",\"answer\":\"Higher OSR2 levels were associated with poorer prognosis in multiple cancers, and OSR2 correlated with clinical factors such as age, gender, and tumor stage.\"}]","Integrating single-cell and spatial transcriptomics with pan-cancer bulk sequencing identifies OSR2 as a multifaceted biomarker for prognosis and tumor immunity | PDF",1790107656,45,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e225009fc809892ce1e3d8d2fdf827d5.webp",983,1310,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4a5fd5f3b48f26abf500b95196c5d9f8.webp",982,1309,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/421126139b36c12d2cae20ceccee2575.webp",981,1308,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8e60a11f242ee902e340cbc8e35ddebe.webp",980,1306]